Mutación de protocadherina 19 (PC-DH19), en paciente con epilepsia refractaria

Paz Pérez, Carmen; Ríos, Loreto; Mesa, Tomás.
Rev. chil. psiquiatr. neurol. infanc. adolesc. (Impr.) ; 31(2): 30-41, ago.2020. ilus
Artículo en Español | LILACS | ID: biblio-1395589

Documentos relacionados

  1. Gain of function due to increased opening probability by two <i>KCNQ5</i> pore variants causing developmental and epileptic encephalopathy.
  2. [Characterization of genetic variants in children with refractory epilepsy].
  3. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE.
  4. Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients.
  5. Pediatric epilepsy surgery from 2000 to 2018: Changes in referral and surgical volumes, patient characteristics, genetic testing, and postsurgical outcomes.
  6. Brain somatic mosaicism in epilepsy: Bringing results back to the clinic.
  7. Experiences of adults living with refractory epilepsy and their views and expectations on receiving results from whole genome sequencing.
  8. RNA therapeutics for epilepsy: An emerging modality for drug discovery.
  9. Drug-resistant epilepsy classified by a phenotyping algorithm associates with NTRK2.
  10. CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy.